These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
366 related articles for article (PubMed ID: 33930070)
21. Which is the preferred site for bone mineral density monitoring as an indicator of treatment-related anti-fracture effect in routine clinical practice? A registry-based cohort study. Leslie WD; Martineau P; Bryanton M; Lix LM Osteoporos Int; 2019 Jul; 30(7):1445-1453. PubMed ID: 31016351 [TBL] [Abstract][Full Text] [Related]
22. Construction of a FRAX® model for the assessment of fracture probability in Canada and implications for treatment. Leslie WD; Lix LM; Langsetmo L; Berger C; Goltzman D; Hanley DA; Adachi JD; Johansson H; Oden A; McCloskey E; Kanis JA Osteoporos Int; 2011 Mar; 22(3):817-27. PubMed ID: 21161509 [TBL] [Abstract][Full Text] [Related]
23. How well do the FRAX (Australia) and Garvan calculators predict incident fractures? Data from the Geelong Osteoporosis Study. Holloway-Kew KL; Zhang Y; Betson AG; Anderson KB; Hans D; Hyde NK; Nicholson GC; Pocock NA; Kotowicz MA; Pasco JA Osteoporos Int; 2019 Oct; 30(10):2129-2139. PubMed ID: 31317250 [TBL] [Abstract][Full Text] [Related]
24. The clinical utility of FRAX to discriminate fracture status in men and women with chronic kidney disease. Jamal SA; West SL; Nickolas TL Osteoporos Int; 2014 Jan; 25(1):71-6. PubMed ID: 24114399 [TBL] [Abstract][Full Text] [Related]
25. [Influence on adjacent lumbar bone density after strengthening of T12, L1 segment vertebral osteoporotic compression fracture by percutaneous vertebroplasty and percutaneous kyphoplasty]. Zhang C; Zhu K; Zhou J; Zhou X; Niu G; Wu M; Shao C Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2013 Jul; 27(7):819-23. PubMed ID: 24063170 [TBL] [Abstract][Full Text] [Related]
26. Geriatric nutritional risk index as a predictor for fragility fracture risk in elderly with type 2 diabetes mellitus: A 9-year ambispective longitudinal cohort study. Pan J; Xu G; Zhai Z; Sun J; Wang Q; Huang X; Guo Y; Lu Q; Mo J; Nong Y; Huang J; Lu W Clin Nutr; 2024 May; 43(5):1125-1135. PubMed ID: 38583354 [TBL] [Abstract][Full Text] [Related]
27. Fracture prediction and calibration of a Canadian FRAX® tool: a population-based report from CaMos. Fraser LA; Langsetmo L; Berger C; Ioannidis G; Goltzman D; Adachi JD; Papaioannou A; Josse R; Kovacs CS; Olszynski WP; Towheed T; Hanley DA; Kaiser SM; Prior J; Jamal S; Kreiger N; Brown JP; Johansson H; Oden A; McCloskey E; Kanis JA; Leslie WD; Osteoporos Int; 2011 Mar; 22(3):829-37. PubMed ID: 21161508 [TBL] [Abstract][Full Text] [Related]
28. Vertebral fracture assessment by dual-energy X-ray absorptiometry along with bone mineral density in the evaluation of postmenopausal osteoporosis. Shetty S; John B; Mohan S; Paul TV Arch Osteoporos; 2020 Feb; 15(1):25. PubMed ID: 32095943 [TBL] [Abstract][Full Text] [Related]
29. Agreement between FRAX scores calculated with and without bone mineral density in women with osteopenia in Turkey. Olmez Sarikaya N; Kapar Yavasi S; Tan G; Satiroglu S; Yildiz AH; Oz B; Yoleri O; Memis A Clin Rheumatol; 2014 Dec; 33(12):1785-9. PubMed ID: 24474067 [TBL] [Abstract][Full Text] [Related]
30. Performance of fracture risk assessment tool in HIV-positive male individuals aged ≥45 years on suppressive antiretroviral therapy. Tsai MS; Zhang JY; Sun HY; Liu WC; Wu PY; Yang CJ; Hung CC J Int AIDS Soc; 2019 Aug; 22(8):e25383. PubMed ID: 31423752 [TBL] [Abstract][Full Text] [Related]
31. Comparison of fracture risk assessment tools in older men without prior hip or spine fracture: the MrOS study. Gourlay ML; Ritter VS; Fine JP; Overman RA; Schousboe JT; Cawthon PM; Orwoll ES; Nguyen TV; Lane NE; Cummings SR; Kado DM; Lapidus JA; Diem SJ; Ensrud KE; Arch Osteoporos; 2017 Oct; 12(1):91. PubMed ID: 29052793 [TBL] [Abstract][Full Text] [Related]
32. Performance of FRAX in a cohort of community-dwelling, ambulatory older men: the Osteoporotic Fractures in Men (MrOS) study. Ettinger B; Ensrud KE; Blackwell T; Curtis JR; Lapidus JA; Orwoll ES; Osteoporos Int; 2013 Apr; 24(4):1185-93. PubMed ID: 23179575 [TBL] [Abstract][Full Text] [Related]
33. Association between trabecular bone score and risk factors for fractures in Korean female patients with rheumatoid arthritis. Kim D; Cho SK; Kim JY; Choi YY; Sung YK Mod Rheumatol; 2016 Jul; 26(4):540-5. PubMed ID: 26418481 [TBL] [Abstract][Full Text] [Related]
34. Effect of abaloparatide on vertebral, nonvertebral, major osteoporotic, and clinical fractures in a subset of postmenopausal women at increased risk of fracture by FRAX probability. McCloskey EV; Fitzpatrick LA; Hu MY; Williams G; Kanis JA Arch Osteoporos; 2019 Feb; 14(1):15. PubMed ID: 30719589 [TBL] [Abstract][Full Text] [Related]
36. Effect of Discordant Hip Bone Density on Incident Fracture Risk: A Registry-Based Cohort Study. Leslie WD; Morin SN; Lix LM; McCloskey EV; Johansson H; Harvey NC; Kanis JA J Bone Miner Res; 2022 Oct; 37(10):2018-2024. PubMed ID: 36069122 [TBL] [Abstract][Full Text] [Related]
37. FRAX for fracture prediction shorter and longer than 10 years: the Manitoba BMD registry. Leslie WD; Majumdar SR; Morin SN; Lix LM; Johansson H; Oden A; McCloskey EV; Kanis JA Osteoporos Int; 2017 Sep; 28(9):2557-2564. PubMed ID: 28593449 [TBL] [Abstract][Full Text] [Related]
38. Efficacy of weekly teriparatide does not vary by baseline fracture probability calculated using FRAX. Harvey NC; Kanis JA; Odén A; Nakamura T; Shiraki M; Sugimoto T; Kuroda T; Johansson H; McCloskey EV Osteoporos Int; 2015 Sep; 26(9):2347-53. PubMed ID: 26092062 [TBL] [Abstract][Full Text] [Related]
39. Performance of FRAX in clinical practice according to sex and osteoporosis definitions: the Manitoba BMD registry. Leslie WD; Majumdar SR; Morin SN; Lix LM; Schousboe JT; Ensrud KE; Johansson H; McCloskey EV; Kanis JA Osteoporos Int; 2018 Mar; 29(3):759-767. PubMed ID: 29404625 [TBL] [Abstract][Full Text] [Related]